{"id":"https://openalex.org/W7220460341","doi":"https://doi.org/10.3389/fcvm.2026.1884708","title":"Serum 25-hydroxyvitamin D, systemic immune-inflammation index, and atherogenic index of plasma in statin-untreated type 2 diabetes: a cross-sectional mediation analysis","display_name":"Serum 25-hydroxyvitamin D, systemic immune-inflammation index, and atherogenic index of plasma in statin-untreated type 2 diabetes: a cross-sectional mediation analysis","publication_year":2026,"publication_date":"2026-10-05","ids":{"openalex":"https://openalex.org/W7220460341","doi":"https://doi.org/10.3389/fcvm.2026.1884708","pmid":"https://pubmed.ncbi.nlm.nih.gov/42898554","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13677915"},"language":"en","primary_location":{"id":"doi:10.3389/fcvm.2026.1884708","doi":"https://doi.org/10.3389/fcvm.2026.1884708","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2026.1884708","pdf_url":"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.1884708/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.1884708/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049266385","display_name":"H\u00fcseyin Avni F\u0131nd\u0131kl\u0131","orcid":"https://orcid.org/0000-0002-9334-7470","observed_orcids":["https://orcid.org/0000-0002-9334-7470"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"H\u00fcseyin Avni F\u0131nd\u0131kl\u0131","raw_affiliation_strings":["Department of Internal Medicine, Kahramanmara\u015f Necip Faz\u0131l City Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Kahramanmara\u015f Necip Faz\u0131l City Hospital","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090773230","display_name":"Vehbi \u015eirik\u00e7i","orcid":"https://orcid.org/0000-0002-5071-025X","observed_orcids":["https://orcid.org/0000-0002-5071-025X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vehbi \u015eirik\u00e7i","raw_affiliation_strings":["Department of Internal Medicine, Kahramanmara\u015f Necip Faz\u0131l City Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Kahramanmara\u015f Necip Faz\u0131l City Hospital","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5049266385"],"corresponding_institution_ids":[],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.74634706,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":null,"first_page":"1884708","last_page":"1884708"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10277","display_name":"Vitamin D Research Studies","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10277","display_name":"Vitamin D Research Studies","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.02419999986886978,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/25-hydroxyvitamin-d","display_name":"25-hydroxyvitamin D","score":0.9490000009536743},{"id":"https://openalex.org/keywords/vitamin-d-deficiency","display_name":"vitamin D deficiency","score":0.875},{"id":"https://openalex.org/keywords/systemic-immune-inflammation-index","display_name":"systemic immune-inflammation index","score":0.9350000023841858},{"id":"https://openalex.org/keywords/atherogenic-index-of-plasma","display_name":"atherogenic index of plasma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8970000147819519},{"id":"https://openalex.org/keywords/systemic-inflammation","display_name":"systemic inflammation","score":0.9229999780654907},{"id":"https://openalex.org/keywords/atherogenic-lipid-profile","display_name":"atherogenic lipid profile","score":0.8539999723434448},{"id":"https://openalex.org/keywords/mediation-analysis","display_name":"mediation analysis","score":0.6150000095367432},{"id":"https://openalex.org/keywords/neutrophil-to-lymphocyte-ratio","display_name":"neutrophil-to-lymphocyte ratio","score":0.9570000171661377},{"id":"https://openalex.org/keywords/monocyte-to-lymphocyte-ratio","display_name":"monocyte-to-lymphocyte ratio","score":0.8920000195503235},{"id":"https://openalex.org/keywords/platelet-to-lymphocyte-ratio","display_name":"platelet-to-lymphocyte ratio","score":0.9779999852180481}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7257999777793884},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6603000164031982},{"id":"https://openalex.org/C179420905","wikidata":"https://www.wikidata.org/wiki/Q223871","display_name":"Mediation","level":2,"score":0.5740000009536743},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.49000000953674316},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.47429999709129333},{"id":"https://openalex.org/C117220453","wikidata":"https://www.wikidata.org/wiki/Q5172842","display_name":"Correlation","level":2,"score":0.38499999046325684},{"id":"https://openalex.org/C2777382242","wikidata":"https://www.wikidata.org/wiki/Q6017816","display_name":"Index (typography)","level":2,"score":0.33379998803138733},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3244999945163727},{"id":"https://openalex.org/C2778270857","wikidata":"https://www.wikidata.org/wiki/Q2723972","display_name":"Lipid profile","level":3,"score":0.3001999855041504},{"id":"https://openalex.org/C142853389","wikidata":"https://www.wikidata.org/wiki/Q744778","display_name":"Association (psychology)","level":2,"score":0.29249998927116394},{"id":"https://openalex.org/C2994423189","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Total cholesterol","level":3,"score":0.2831999957561493},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.27410000562667847},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.27250000834465027},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.26190000772476196},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.250900000333786},{"id":"https://openalex.org/C3017575891","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma levels","level":2,"score":0.25060001015663147}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fcvm.2026.1884708","doi":"https://doi.org/10.3389/fcvm.2026.1884708","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2026.1884708","pdf_url":"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.1884708/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13677915","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13677915/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13677915/pdf/fcvm-13-1884708.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Cardiovasc Med","raw_type":"Text"},{"id":"pmid:42898554","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42898554","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in cardiovascular medicine","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:942dd31bf71846ba833dd05ee98ccab5","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/942dd31bf71846ba833dd05ee98ccab5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Cardiovascular Medicine, Vol 13 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fcvm.2026.1884708","doi":"https://doi.org/10.3389/fcvm.2026.1884708","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2026.1884708","pdf_url":"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.1884708/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220460341.pdf","grobid_xml":"https://content.openalex.org/works/W7220460341.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1829202101","https://openalex.org/W2000030095","https://openalex.org/W2153059487","https://openalex.org/W2158627589","https://openalex.org/W2170888045","https://openalex.org/W2340325420","https://openalex.org/W2611589877","https://openalex.org/W2762350070","https://openalex.org/W3038060515","https://openalex.org/W3080411302","https://openalex.org/W3200962100","https://openalex.org/W3201595862","https://openalex.org/W3208972144","https://openalex.org/W4206778351","https://openalex.org/W4290547583","https://openalex.org/W4376614568","https://openalex.org/W4384405424","https://openalex.org/W4401483921","https://openalex.org/W4403647294","https://openalex.org/W4403977325","https://openalex.org/W4404712061","https://openalex.org/W4406727148","https://openalex.org/W4406937568","https://openalex.org/W4409147847","https://openalex.org/W4413009750","https://openalex.org/W7119935921"],"related_works":["https://openalex.org/W3159049409","https://openalex.org/W7220857134","https://openalex.org/W2055837520","https://openalex.org/W2793436840","https://openalex.org/W4321503215","https://openalex.org/W3151547198","https://openalex.org/W3038306293","https://openalex.org/W4248459284","https://openalex.org/W2091761399","https://openalex.org/W2736691325"],"abstract_inverted_index":{"This":[0],"cross-sectional":[1,273],"study":[2],"investigated":[3],"the":[4,30,33,134,150,156,193,234,272,286],"associations":[5,146],"between":[6,137,264],"serum":[7,55,96],"25-hydroxyvitamin":[8],"D":[9,266],"[25(OH)D]":[10],"levels,":[11],"systemic":[12,34,262],"inflammatory":[13],"burden,":[14],"and":[15,65,80,111,139,153,158,171,181,268],"atherogenic":[16,113,269],"lipid":[17],"profile":[18],"in":[19,95,188,199],"statin-untreated":[20,42],"adults":[21],"with":[22,26,44,77,101,173,212,224,256],"type":[23,45],"2":[24,46],"diabetes,":[25],"particular":[27],"emphasis":[28],"on":[29],"contribution":[31],"of":[32,40,115,133,175,210,245],"immune-inflammation":[35],"index":[36,114],"(SII).":[37],"A":[38],"total":[39,135],"619":[41],"patients":[43,211],"diabetes":[47],"were":[48,51,85,147,186],"included.":[49],"Participants":[50],"stratified":[52],"according":[53],"to":[54,205,239],"25(OH)D":[56,97,138],"concentrations":[57],"into":[58],"deficient":[59],"(<20":[60],"ng/mL),":[61,64,216],"insufficient":[62],"(20\u201329.9":[63],"sufficient":[66],"(\u226530":[67],"ng/mL)":[68],"groups.":[69],"Multivariable":[70],"linear":[71],"regression,":[72],"BCa":[73],"bootstrap":[74],"mediation":[75],"analysis":[76,229],"5,000":[78],"resamples,":[79],"restricted":[81],"cubic":[82,162],"spline":[83,163],"models":[84],"used.":[86],"In":[87,226],"fully":[88],"adjusted":[89],"models,":[90],"each":[91],"10":[92],"ng/mL":[93,180,283],"decrease":[94],"was":[98,196,237],"independently":[99],"associated":[100],"higher":[102,112],"SII":[103,129,170],"(\u03b2=0.064,":[104],"95%":[105,119,142,202],"CI":[106,120,143,203],"0.023\u20130.105;":[107],"p":[108,122],"=":[109,123],"0.002)":[110],"plasma":[116],"(AIP;":[117],"\u03b2=0.031,":[118],"0.009\u20130.053;":[121],"0.006).":[124],"The":[125,252,278],"indirect":[126,194,235,259],"association":[127,136,195,236],"through":[128],"accounted":[130],"for":[131,149,155,168,230],"26.5%":[132],"AIP":[140],"(bootstrap":[141],"12.8\u201343.1).":[144],"Indirect":[145],"weaker":[148],"neutrophil-to-lymphocyte":[151],"ratio":[152],"non-significant":[154],"monocyte-to-lymphocyte":[157],"platelet-to-lymphocyte":[159],"ratios.":[160],"Restricted":[161],"analyses":[164],"demonstrated":[165],"significant":[166,198,222],"non-linearity":[167],"both":[169],"AIP,":[172],"points":[174],"maximal":[176],"curvature":[177],"at":[178,241],"18.7":[179],"19.6":[182],"ng/mL,":[183],"respectively.":[184],"Estimates":[185],"similar":[187],"overlapping":[189],"laboratory":[190],"subgroups,":[191],"but":[192,271],"not":[197],"men":[200],"(19.2%,":[201],"\u22127.6":[204],"39.4)":[206],"or":[207],"after":[208],"exclusion":[209],"severe":[213],"deficiency":[214],"(<10":[215],"although":[217],"formal":[218],"testing":[219],"showed":[220],"no":[221],"interaction":[223],"sex.":[225],"a":[227,242,257],"sensitivity":[228],"unmeasured":[231],"mediator\u2013outcome":[232],"confounding,":[233],"reduced":[238],"zero":[240],"residual":[243],"correlation":[244],"only":[246],"\u03c1":[247],"=0.20,":[248],"indicating":[249],"limited":[250],"robustness.":[251],"findings":[253],"are":[254],"compatible":[255],"statistical":[258],"relationship":[260],"involving":[261],"inflammation":[263],"vitamin":[265],"status":[267],"dyslipidaemia,":[270],"design":[274],"precludes":[275],"causal":[276],"inference.":[277],"non-linear":[279],"pattern":[280],"near":[281],"20":[282],"suggests":[284],"that":[285],"inflammatory\u2013atherogenic":[287],"phenotype":[288],"may":[289],"become":[290],"more":[291],"pronounced":[292],"below":[293],"this":[294],"threshold.":[295]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2026-10-06T00:00:00"}